Subjects With Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vegfr-Targeted Therapy
Posted Date: May 17, 2019
- Investigator: David Steward
- Specialties: Oncology, Otolaryngology, Thyroid Cancer
- Type of Study: Drug
The purpose of this study is to evaluate the effect of cabozantinib compared with a placebo in treating patients whose disease has progressed after receiving prior treatment with drugs that inhibit growth of tumor blood vessel (VEGFR-targeted therapy) for their thyroid cancer.
Thyroid Cancer, Cabozantinib
For More Information: